the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Murder trial set on Feb 20 for suspect behind death of 3 UiTM students

PETALING JAYA: The suspect behind the wheel which caused an accident that killed three Universiti Teknologi Mara (UiTM) students in Dungun, Terengganu, last year, will be tried in court following the results of her psychiatry report.

According to Buletin TV3, magistrate Nur Amira Fatihah Osman fixed Feb 20 for Norizan Ismail, 50, to appear in the Dungun magistrates’ court prior to being tried in the High Court.

Nur Amira came up with the decision during the case management session on Norizan’s completed psychiatry report.

Norizan, a housewife, was previously charged with murder for causing the deaths of Akmal Tukirin, 25, and Ku Adib Aizad Ku Azmi and Khairil Anuar Jamaluddin, both 20.

ALSO READ: Woman charged with UiTM Dungun students’ deaths still undergoing mental evaluation

She was charged with committing the offence at Jalan Pantai in front of UiTM Dungun at 7.35pm on Oct 9 last year.

The charge was made under Section 302 of the Penal Code, which provides for the death sentence or no less than 30 years’ imprisonment and no less than 12 strokes of the rotan.

The prosecution was led by deputy public prosecutor Nur Azhani Azman, while Norizan was represented by Norhabibah Norulalzahar.

In the incident, Norizan had driven an SUV into two motorcycles ridden by four students on their way back to campus.

Ku Adib, Khairil, and Akmal perished at the scene while the other victim, Ammar Danish Ridhuan, 20, was injured.

ALSO READ: Three UiTM students die after car collides with motorcycles

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings